<img alt="" src="https://www.24-enterprisingoffice.com/807724.png" style="display:none;">
Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners
Sep 17, 2025 9:08:36 AM 3 min read
Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
Isto Biologics Elevates Biologic Innovations Through Merger with Advanced Biologics/Biologica Technologies
Oct 18, 2023 2:15:00 PM 2 min read
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
Jun 21, 2022 1:15:00 PM 2 min read

 

April 25

AANS

April 25-28
Boston, MA

April 25
May 1

WPMA

May 1-3
Brookfield, WI

May 1
May 1

Rush Spine Forum

May 1-3
Scottsdale, AZ

May 1
May 1

GNS 2025

May 23-25
Sea Island, GA

May 1
May 1

ESTROT 

May 30 - Jun 1
Leeds, UK

May 1
May 1

State of Spine 

Jun 26-28
San Jose del Cabo, Mexico

May 1